Uppsala 4 November 2022 – LIDDS announced today that an interview with CEO Anders Månsson has been published on the company's website.
Anders Månsson took office as CEO of LIDDS on September 1, 2022. In an interview, published today on the company's website, he summarizes his view of the company's situation and the way forward.
"I assess that LIDDS has assets that can be developed with a low risk for the biotech industry, and potentially with great value creation, but very important to achieve the latter is a substantial upgrade of the business development," said Anders Månsson. The full interview can be viewed at https://liddspharma.com/en/about-lidds/message-from-the-ceo/ .